James Caruso

President, Chief Executive Officer & Director at Cellectar BioSciences, Inc.

James Caruso

James Caruso

President, Chief Executive Officer & Director at Cellectar BioSciences, Inc.

Overview
Career Highlights

Cellectar BioSciences, Inc.
Novelos Therapeutics, Inc.
Catalyst Medical LLC

RelSci Relationships

979

Number of Boards

3

Birthday

1959

Age

61

Contact Data
Trying to get in touch with James Caruso? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals James Caruso likely has professional access to. A relationship does not necessarily indicate a personal connection.

Venture Partner at ARCH Venture Partners

Relationship likelihood: Strong

Executive Managing Director at Venture Investors LLC

Relationship likelihood: Strong

Former Director, President & Chief Executive Officer at Catalyst Biosciences, Inc.

Relationship likelihood: Strong

Managing Director, Life Sciences, Healthcare at Oppenheimer & Co., Inc.

Relationship likelihood: Strong

Chief Executive Officer at Hip Innovation Technology LLC

Relationship likelihood: Strong

Affiliate Professor, Pharmaceutical Sciences & Professor, Department of Radiology at University of Wisconsin - School of Pharmacy

Relationship likelihood: Strong

Chief Business Development & Strategy Officer at Athenex, Inc.

Relationship likelihood: Strong

Former Managing Director at Stifel, Nicolaus & Co., Inc.

Relationship likelihood: Strong

Former Chief Financial Officer at Flexion Therapeutics, Inc.

Relationship likelihood: Strong

President & Chief Medical Officer at Hip Innovation Technology LLC

Relationship likelihood: Strong

Paths to James Caruso
Potential Connections via
Relationship Science
You
James Caruso
President, Chief Executive Officer & Director at Cellectar BioSciences, Inc.
Education
Undergraduate Degree

University of Nevada functions as a college and university. It provides education, research, scholarship, creative activities, and clinical services. The company was founded on September 10, 1957 and is headquartered in Las Vegas, NV.

Career History
President, Chief Executive Officer & Director
2015 - Current

Cellectar BioSciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma; CLR 125, which intends to treat micro metastatic disease; CLR 124 which could detects tumors and metastases in a broad range of cancers; and CLR 1502, a cancer-targeting near-infrared-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination. The company was founded in June 1996 and is headquartered in Florham Park, NJ.

Director
2010 - Current
Chief Commercial Officer & Executive Vice President
2006 - 2010

Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO.

Boards & Committees
Director
2010 - Current
Transactions
Details Hidden

Cellectar BioSciences, Inc. raised money in a private placement transaction

Details Hidden

Cellectar BioSciences, Inc. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by James Caruso. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of James Caruso's profile does not indicate a business or promotional relationship of any kind between RelSci and James Caruso.